Hamilton Health Sciences Corporation

This study is testing whether an oral drug called tideglusib can help control a genetic heart condition that causes dangerous irregular heartbeats. It will involve 120 people who have a specific gene change linked to the disease and experience frequent extra heartbeats. Participa…

This study aims to see if two common, low-cost drugs can safely reduce dangerous bleeding during surgery for people with advanced kidney disease. It will enroll 100 patients with severe kidney problems who are having non-heart surgery. The trial is a pilot to prepare for a larger…

This study is testing whether a catheter-based heart procedure that closes off a small pouch in the heart (left atrial appendage) can prevent strokes in people with atrial fibrillation. Participants have a high stroke risk despite already taking blood-thinning medications. The tr…

This study is testing whether a targeted numbing injection during minimally invasive pituitary surgery helps control pain afterward. About 108 patients will be randomly assigned to receive either the numbing medication, a saltwater placebo injection, or no extra injection during …